|
業務類別
|
Biotechnology |
|
業務概覽
|
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxietydisorders. |
| 公司地址
| 677 N. Washington Boulevard, Sarasota, FL, USA, 34236 |
| 電話號碼
| +1 718 400-9031 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.silopharma.com |
| 員工數量
| 3 |
| Mr. Eric Weisblum |
Chairman of the Board, Chief Executive Officer and President |
美元 350.00K |
05/09/2025 |
| Mr. Daniel E. Ryweck |
Chief Financial Officer and Principal Accounting Officer |
美元 60.00K |
05/09/2025 |
|
|
| Dr. Kevin Munoz |
Independent Director |
05/09/2025 |
| Mr. Eric Weisblum |
Chairman of the Board, Chief Executive Officer and President |
05/09/2025 |
| Dr. Jeff Pavell, M.D. |
Independent Director |
05/09/2025 |
| Mr. Wayne D. Linsley |
Independent Director |
05/09/2025 |
|
|
|
|
